These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34188109)

  • 1. Serum neurofilament light chain as a severity marker for spinocerebellar ataxia.
    Shin HR; Moon J; Lee WJ; Lee HS; Kim EY; Shin S; Lee ST; Jung KH; Park KI; Jung KY; Lee SK; Chu K
    Sci Rep; 2021 Jun; 11(1):13517. PubMed ID: 34188109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
    Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
    Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study.
    Wilke C; Bender F; Hayer SN; Brockmann K; Schöls L; Kuhle J; Synofzik M
    J Neurol; 2018 Jul; 265(7):1618-1624. PubMed ID: 29737427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Level of Neurofilament Light With Disease Severity in Patients With Spinocerebellar Ataxia Type 2.
    Yang L; Shao YR; Li XY; Ma Y; Dong Y; Wu ZY
    Neurology; 2021 Dec; 97(24):e2404-e2413. PubMed ID: 34706976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NfL and pNfH are increased in Friedreich's ataxia.
    Hayer SN; Liepelt I; Barro C; Wilke C; Kuhle J; Martus P; Schöls L;
    J Neurol; 2020 May; 267(5):1420-1430. PubMed ID: 32002649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
    Gaiottino J; Norgren N; Dobson R; Topping J; Nissim A; Malaspina A; Bestwick JP; Monsch AU; Regeniter A; Lindberg RL; Kappos L; Leppert D; Petzold A; Giovannoni G; Kuhle J
    PLoS One; 2013; 8(9):e75091. PubMed ID: 24073237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic assessment of plasma biomarkers in spinocerebellar ataxia.
    Shen XN; Wu KM; Huang YY; Guo Y; Huang SY; Zhang YR; Chen SF; Wang HF; Zhang W; Cheng W; Cui M; Dong Q; Yu JT
    Neurobiol Dis; 2023 Jun; 181():106112. PubMed ID: 37003406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.
    Wilke C; Mengel D; Schöls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Schüle R; Reetz K; Jacobi H; Synofzik M
    Neurology; 2022 May; 98(20):e1985-e1996. PubMed ID: 35264424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
    Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
    Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
    Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
    Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
    Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
    Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
    Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
    PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.
    Veenhuis SJG; Gupta AS; de Gusmão CM; Thornton J; Margus B; Rothblum-Oviatt C; Otto M; Halbgebauer S; van Os NJH; van de Warrenburg BPC; Verbeek MM; Willemsen MAAP
    Eur J Paediatr Neurol; 2021 May; 32():93-97. PubMed ID: 33878608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.
    Sánchez-Valle R; Heslegrave A; Foiani MS; Bosch B; Antonell A; Balasa M; Lladó A; Zetterberg H; Fox NC
    Alzheimers Res Ther; 2018 Nov; 10(1):113. PubMed ID: 30390718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Neurofilament light correlates with CADASIL disease severity and survival.
    Gravesteijn G; Rutten JW; Verberk IMW; Böhringer S; Liem MK; van der Grond J; Aartsma-Rus A; Teunissen CE; Lesnik Oberstein SAJ
    Ann Clin Transl Neurol; 2019 Jan; 6(1):46-56. PubMed ID: 30656183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament light is a novel biomarker for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes.
    Zheng YS; Sun C; Wang R; Chen N; Luo SS; Xi JY; Lu JH; Zhao CB; Li YX; Zhou L; Lin J
    Sci Rep; 2021 Jan; 11(1):2001. PubMed ID: 33479417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
    Weston PSJ; Poole T; Ryan NS; Nair A; Liang Y; Macpherson K; Druyeh R; Malone IB; Ahsan RL; Pemberton H; Klimova J; Mead S; Blennow K; Rossor MN; Schott JM; Zetterberg H; Fox NC
    Neurology; 2017 Nov; 89(21):2167-2175. PubMed ID: 29070659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.
    Kuhle J; Gaiottino J; Leppert D; Petzold A; Bestwick JP; Malaspina A; Lu CH; Dobson R; Disanto G; Norgren N; Nissim A; Kappos L; Hurlbert J; Yong VW; Giovannoni G; Casha S
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):273-9. PubMed ID: 24935984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.